We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





Unique Competition Focuses on Using Data Science to Forecast Preanalytical Errors

By LabMedica International staff writers
Posted on 27 Jul 2023

Many institutions grapple with the issue of excess hemolyzed samples and are keen to understand how to address this problem while preserving scarce resources. More...

The AACC session titled "Data Analytics Competition: Forecasting Future Preanalytical Errors" focused on this very issue.

At the session, Mark Zaydman, MD, Ph.D., from Washington University in St. Louis (WUSTL, St. Louis, MO, USA) announced the winners of a unique competition focused on utilizing data science to predict preanalytical errors arising from incorrect blood specimen collection. The session highlighted the lessons that medical lab professionals could learn from this competition. Co-hosted by the Section of Pathology Informatics of Washington University in St. Louis and the ADLM Data Analytics Steering Committee, the competition used a machine-learning and data-science platform called Kaggle to crowdsource solutions for problems across disciplines.

The competition for this year, titled "Help with Hemolysis," provided a real-world, anonymized dataset reflecting hemolysis within the clinical lab. Contestants had to use this dataset to determine which blood-specimen collectors could gain the most from training in phlebotomy best practices. The idea was to discover ways to reduce in vitro hemolysis while effectively using laboratory time and resources. The winning solution could guide institutions on how to better allocate their training resources. While educational interventions can help reduce hemolysis, they can be expensive and temporary, especially with a high staff turnover. A total of 18 participating teams had slightly over a month to work with the provided dataset before submitting their solution and also had to submit their code to demonstrate their problem-solving approach.

After providing an overview of the competition and summarizing the strategies adopted by the teams, Zaydman announced the winning team—Team Hemolyers. The winning team then shared their solution, offering attendees the opportunity to learn more about them, their approach to the problem, and ask any questions. The session's innovative teaching style differed from the conventional lecture format, aiming to cater to individuals of varying levels of experience. The format of the competition, which is into its second year, provided a novel way to learn, foster a collaborative community, and discover powerful solutions for real-world problems. Zaydman who had hosted the first competition as well pointed out that interdisciplinary teams—combining clinical lab expertise and computer-science knowledge—had been the winners both the times. This was mainly attributed to the increasing accessibility of data science tools and computational resources to individuals without advanced data science degrees. Such interdisciplinary teams can identify gaps in patient care and collaborate to develop innovative and viable solutions.

Despite the particular difficulty of the task for this year's competition, Zaydman stressed that the results were remarkable. “A valuable model doesn’t have to be perfect, as long as it saves costs and improves patient care,” he said.

Related Links:
WUSTL


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Chlamydia Pneumoniae Test
Chlamydia Pneumoniae (CP) Real Time PCR Kit
New
mRNA Extraction Kits
TurboCapture mRNA Kits
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.